Skip to main content


Media Coverage

Supreme Court Biosimilar Decision — What Developers Need To Know

20 July 2017
Biosimilar Development
Bylined article by Intellectual Property partner Lisa Ferri (New York) and Litigation & Dispute Resolution partner Christopher Mikson (Washington DC).

Related Information

  • Related People
    Lisa M. Ferri
    T +1 212 506 2340
    Christopher M. Mikson, MD
    T +1 202 263 3157
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.